Industry Research Reports

Home > Reports > Chemical & Material > Global Voriconazole API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Voriconazole API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-15

Pages: 98 Pages

Report ld: 3966232

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Voriconazole API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Voriconazole API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Voriconazole API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

Dr. Reddy's Laboratories
Murli Krishna Pharma
SGMR Pharmaceuticals
Medichem
Hunan Huateng Pharmaceutical
Glenmark Pharmaceuticals
ST Pharma
Synergene
Rundu Pharmaceutical
Zhejiang Huahai Pharmaceutical
Neuland Lab

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Oral Grade
Injection Grade

Segment by Application

Voriconazole Tablets
Voriconazole Injection

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales and revenue of Voriconazole API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Voriconazole API manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Voriconazole API revenue, gross margin, and recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Sales channels analysis

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Voriconazole API Product Scope

1.2 Voriconazole API by Type

1.2.1 Global Voriconazole API Sales by Type (2020 & 2024 & 2031)

1.2.2 Oral Grade

1.2.3 Injection Grade

1.3 Voriconazole API by Application

1.3.1 Global Voriconazole API Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Voriconazole Tablets

1.3.3 Voriconazole Injection

1.4 Global Voriconazole API Market Estimates and Forecasts (2020-2031)

1.4.1 Global Voriconazole API Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Voriconazole API Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Voriconazole API Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Voriconazole API Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Voriconazole API Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Voriconazole API Sales Market Share by Region (2020-2025)

2.2.2 Global Voriconazole API Revenue Market Share by Region (2020-2025)

2.3 Global Voriconazole API Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Voriconazole API Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Voriconazole API Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Voriconazole API Market Size and Prospective (2020-2031)

2.4.2 Europe Voriconazole API Market Size and Prospective (2020-2031)

2.4.3 China Voriconazole API Market Size and Prospective (2020-2031)

2.4.4 Japan Voriconazole API Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Voriconazole API Historic Market Review by Type (2020-2025)

3.1.1 Global Voriconazole API Sales by Type (2020-2025)

3.1.2 Global Voriconazole API Revenue by Type (2020-2025)

3.1.3 Global Voriconazole API Price by Type (2020-2025)

3.2 Global Voriconazole API Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Voriconazole API Sales Forecast by Type (2026-2031)

3.2.2 Global Voriconazole API Revenue Forecast by Type (2026-2031)

3.2.3 Global Voriconazole API Price Forecast by Type (2026-2031)

3.3 Different Types Voriconazole API Representative Players

4 Global Market Size by Application

4.1 Global Voriconazole API Historic Market Review by Application (2020-2025)

4.1.1 Global Voriconazole API Sales by Application (2020-2025)

4.1.2 Global Voriconazole API Revenue by Application (2020-2025)

4.1.3 Global Voriconazole API Price by Application (2020-2025)

4.2 Global Voriconazole API Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Voriconazole API Sales Forecast by Application (2026-2031)

4.2.2 Global Voriconazole API Revenue Forecast by Application (2026-2031)

4.2.3 Global Voriconazole API Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Voriconazole API Application

5 Competition Landscape by Players

5.1 Global Voriconazole API Sales by Players (2020-2025)

5.2 Global Top Voriconazole API Players by Revenue (2020-2025)

5.3 Global Voriconazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Voriconazole API as of 2024)

5.4 Global Voriconazole API Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Voriconazole API, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Voriconazole API, Product Type & Application

5.7 Global Key Manufacturers of Voriconazole API, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Voriconazole API Sales by Company

6.1.1.1 North America Voriconazole API Sales by Company (2020-2025)

6.1.1.2 North America Voriconazole API Revenue by Company (2020-2025)

6.1.2 North America Voriconazole API Sales Breakdown by Type (2020-2025)

6.1.3 North America Voriconazole API Sales Breakdown by Application (2020-2025)

6.1.4 North America Voriconazole API Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Voriconazole API Sales by Company

6.2.1.1 Europe Voriconazole API Sales by Company (2020-2025)

6.2.1.2 Europe Voriconazole API Revenue by Company (2020-2025)

6.2.2 Europe Voriconazole API Sales Breakdown by Type (2020-2025)

6.2.3 Europe Voriconazole API Sales Breakdown by Application (2020-2025)

6.2.4 Europe Voriconazole API Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Voriconazole API Sales by Company

6.3.1.1 China Voriconazole API Sales by Company (2020-2025)

6.3.1.2 China Voriconazole API Revenue by Company (2020-2025)

6.3.2 China Voriconazole API Sales Breakdown by Type (2020-2025)

6.3.3 China Voriconazole API Sales Breakdown by Application (2020-2025)

6.3.4 China Voriconazole API Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Voriconazole API Sales by Company

6.4.1.1 Japan Voriconazole API Sales by Company (2020-2025)

6.4.1.2 Japan Voriconazole API Revenue by Company (2020-2025)

6.4.2 Japan Voriconazole API Sales Breakdown by Type (2020-2025)

6.4.3 Japan Voriconazole API Sales Breakdown by Application (2020-2025)

6.4.4 Japan Voriconazole API Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Dr. Reddy's Laboratories

7.1.1 Dr. Reddy's Laboratories Company Information

7.1.2 Dr. Reddy's Laboratories Business Overview

7.1.3 Dr. Reddy's Laboratories Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Dr. Reddy's Laboratories Voriconazole API Products Offered

7.1.5 Dr. Reddy's Laboratories Recent Development

7.2 Murli Krishna Pharma

7.2.1 Murli Krishna Pharma Company Information

7.2.2 Murli Krishna Pharma Business Overview

7.2.3 Murli Krishna Pharma Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Murli Krishna Pharma Voriconazole API Products Offered

7.2.5 Murli Krishna Pharma Recent Development

7.3 SGMR Pharmaceuticals

7.3.1 SGMR Pharmaceuticals Company Information

7.3.2 SGMR Pharmaceuticals Business Overview

7.3.3 SGMR Pharmaceuticals Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.3.4 SGMR Pharmaceuticals Voriconazole API Products Offered

7.3.5 SGMR Pharmaceuticals Recent Development

7.4 Medichem

7.4.1 Medichem Company Information

7.4.2 Medichem Business Overview

7.4.3 Medichem Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Medichem Voriconazole API Products Offered

7.4.5 Medichem Recent Development

7.5 Hunan Huateng Pharmaceutical

7.5.1 Hunan Huateng Pharmaceutical Company Information

7.5.2 Hunan Huateng Pharmaceutical Business Overview

7.5.3 Hunan Huateng Pharmaceutical Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Hunan Huateng Pharmaceutical Voriconazole API Products Offered

7.5.5 Hunan Huateng Pharmaceutical Recent Development

7.6 Glenmark Pharmaceuticals

7.6.1 Glenmark Pharmaceuticals Company Information

7.6.2 Glenmark Pharmaceuticals Business Overview

7.6.3 Glenmark Pharmaceuticals Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Glenmark Pharmaceuticals Voriconazole API Products Offered

7.6.5 Glenmark Pharmaceuticals Recent Development

7.7 ST Pharma

7.7.1 ST Pharma Company Information

7.7.2 ST Pharma Business Overview

7.7.3 ST Pharma Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.7.4 ST Pharma Voriconazole API Products Offered

7.7.5 ST Pharma Recent Development

7.8 Synergene

7.8.1 Synergene Company Information

7.8.2 Synergene Business Overview

7.8.3 Synergene Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Synergene Voriconazole API Products Offered

7.8.5 Synergene Recent Development

7.9 Rundu Pharmaceutical

7.9.1 Rundu Pharmaceutical Company Information

7.9.2 Rundu Pharmaceutical Business Overview

7.9.3 Rundu Pharmaceutical Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Rundu Pharmaceutical Voriconazole API Products Offered

7.9.5 Rundu Pharmaceutical Recent Development

7.10 Zhejiang Huahai Pharmaceutical

7.10.1 Zhejiang Huahai Pharmaceutical Company Information

7.10.2 Zhejiang Huahai Pharmaceutical Business Overview

7.10.3 Zhejiang Huahai Pharmaceutical Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Zhejiang Huahai Pharmaceutical Voriconazole API Products Offered

7.10.5 Zhejiang Huahai Pharmaceutical Recent Development

7.11 Neuland Lab

7.11.1 Neuland Lab Company Information

7.11.2 Neuland Lab Business Overview

7.11.3 Neuland Lab Voriconazole API Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Neuland Lab Voriconazole API Products Offered

7.11.5 Neuland Lab Recent Development

8 Voriconazole API Manufacturing Cost Analysis

8.1 Voriconazole API Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Voriconazole API

8.4 Voriconazole API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Voriconazole API Distributors List

9.3 Voriconazole API Customers

10 Voriconazole API Market Dynamics

10.1 Voriconazole API Industry Trends

10.2 Voriconazole API Market Drivers

10.3 Voriconazole API Market Challenges

10.4 Voriconazole API Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Voriconazole API Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Voriconazole API Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Voriconazole API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Voriconazole API Sales (Ton) by Region (2020-2025)

Table 5. Global Voriconazole API Sales Market Share by Region (2020-2025)

Table 6. Global Voriconazole API Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Voriconazole API Revenue Share by Region (2020-2025)

Table 8. Global Voriconazole API Sales (Ton) Forecast by Region (2026-2031)

Table 9. Global Voriconazole API Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Voriconazole API Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Voriconazole API Revenue Share Forecast by Region (2026-2031)

Table 12. Global Voriconazole API Sales by Type (Ton) & (2020-2025)

Table 13. Global Voriconazole API Sales Share by Type (2020-2025)

Table 14. Global Voriconazole API Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Voriconazole API Price by Type (US$/Ton) & (2020-2025)

Table 16. Global Voriconazole API Sales by Type (Ton) & (2026-2031)

Table 17. Global Voriconazole API Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Voriconazole API Price by Type (US$/Ton) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Voriconazole API Sales by Application (Ton) & (2020-2025)

Table 21. Global Voriconazole API Sales Share by Application (2020-2025)

Table 22. Global Voriconazole API Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Voriconazole API Price by Application (US$/Ton) & (2020-2025)

Table 24. Global Voriconazole API Sales by Application (Ton) & (2026-2031)

Table 25. Global Voriconazole API Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Voriconazole API Price by Application (US$/Ton) & (2026-2031)

Table 27. New Sources of Growth in Voriconazole API Application

Table 28. Global Voriconazole API Sales by Company (Ton) & (2020-2025)

Table 29. Global Voriconazole API Sales Share by Company (2020-2025)

Table 30. Global Voriconazole API Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Voriconazole API Revenue Share by Company (2020-2025)

Table 32. Global Voriconazole API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Voriconazole API as of 2024)

Table 33. Global Market Voriconazole API Average Price by Company (US$/Ton) & (2020-2025)

Table 34. Global Key Manufacturers of Voriconazole API, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Voriconazole API, Product Type & Application

Table 36. Global Key Manufacturers of Voriconazole API, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Voriconazole API Sales by Company (2020-2025) & (Ton)

Table 39. North America Voriconazole API Sales Market Share by Company (2020-2025)

Table 40. North America Voriconazole API Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Voriconazole API Revenue Market Share by Company (2020-2025)

Table 42. North America Voriconazole API Sales by Type (2020-2025) & (Ton)

Table 43. North America Voriconazole API Sales Market Share by Type (2020-2025)

Table 44. North America Voriconazole API Sales by Application (2020-2025) & (Ton)

Table 45. North America Voriconazole API Sales Market Share by Application (2020-2025)

Table 46. Europe Voriconazole API Sales by Company (2020-2025) & (Ton)

Table 47. Europe Voriconazole API Sales Market Share by Company (2020-2025)

Table 48. Europe Voriconazole API Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Voriconazole API Revenue Market Share by Company (2020-2025)

Table 50. Europe Voriconazole API Sales by Type (2020-2025) & (Ton)

Table 51. Europe Voriconazole API Sales Market Share by Type (2020-2025)

Table 52. Europe Voriconazole API Sales by Application (2020-2025) & (Ton)

Table 53. Europe Voriconazole API Sales Market Share by Application (2020-2025)

Table 54. China Voriconazole API Sales by Company (2020-2025) & (Ton)

Table 55. China Voriconazole API Sales Market Share by Company (2020-2025)

Table 56. China Voriconazole API Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Voriconazole API Revenue Market Share by Company (2020-2025)

Table 58. China Voriconazole API Sales by Type (2020-2025) & (Ton)

Table 59. China Voriconazole API Sales Market Share by Type (2020-2025)

Table 60. China Voriconazole API Sales by Application (2020-2025) & (Ton)

Table 61. China Voriconazole API Sales Market Share by Application (2020-2025)

Table 62. Japan Voriconazole API Sales by Company (2020-2025) & (Ton)

Table 63. Japan Voriconazole API Sales Market Share by Company (2020-2025)

Table 64. Japan Voriconazole API Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Voriconazole API Revenue Market Share by Company (2020-2025)

Table 66. Japan Voriconazole API Sales by Type (2020-2025) & (Ton)

Table 67. Japan Voriconazole API Sales Market Share by Type (2020-2025)

Table 68. Japan Voriconazole API Sales by Application (2020-2025) & (Ton)

Table 69. Japan Voriconazole API Sales Market Share by Application (2020-2025)

Table 70. Dr. Reddy's Laboratories Company Information

Table 71. Dr. Reddy's Laboratories Description and Business Overview

Table 72. Dr. Reddy's Laboratories Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Dr. Reddy's Laboratories Voriconazole API Product

Table 74. Dr. Reddy's Laboratories Recent Development

Table 75. Murli Krishna Pharma Company Information

Table 76. Murli Krishna Pharma Description and Business Overview

Table 77. Murli Krishna Pharma Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Murli Krishna Pharma Voriconazole API Product

Table 79. Murli Krishna Pharma Recent Development

Table 80. SGMR Pharmaceuticals Company Information

Table 81. SGMR Pharmaceuticals Description and Business Overview

Table 82. SGMR Pharmaceuticals Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. SGMR Pharmaceuticals Voriconazole API Product

Table 84. SGMR Pharmaceuticals Recent Development

Table 85. Medichem Company Information

Table 86. Medichem Description and Business Overview

Table 87. Medichem Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Medichem Voriconazole API Product

Table 89. Medichem Recent Development

Table 90. Hunan Huateng Pharmaceutical Company Information

Table 91. Hunan Huateng Pharmaceutical Description and Business Overview

Table 92. Hunan Huateng Pharmaceutical Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Hunan Huateng Pharmaceutical Voriconazole API Product

Table 94. Hunan Huateng Pharmaceutical Recent Development

Table 95. Glenmark Pharmaceuticals Company Information

Table 96. Glenmark Pharmaceuticals Description and Business Overview

Table 97. Glenmark Pharmaceuticals Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Glenmark Pharmaceuticals Voriconazole API Product

Table 99. Glenmark Pharmaceuticals Recent Development

Table 100. ST Pharma Company Information

Table 101. ST Pharma Description and Business Overview

Table 102. ST Pharma Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. ST Pharma Voriconazole API Product

Table 104. ST Pharma Recent Development

Table 105. Synergene Company Information

Table 106. Synergene Description and Business Overview

Table 107. Synergene Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Synergene Voriconazole API Product

Table 109. Synergene Recent Development

Table 110. Rundu Pharmaceutical Company Information

Table 111. Rundu Pharmaceutical Description and Business Overview

Table 112. Rundu Pharmaceutical Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Rundu Pharmaceutical Voriconazole API Product

Table 114. Rundu Pharmaceutical Recent Development

Table 115. Zhejiang Huahai Pharmaceutical Company Information

Table 116. Zhejiang Huahai Pharmaceutical Description and Business Overview

Table 117. Zhejiang Huahai Pharmaceutical Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Zhejiang Huahai Pharmaceutical Voriconazole API Product

Table 119. Zhejiang Huahai Pharmaceutical Recent Development

Table 120. Neuland Lab Company Information

Table 121. Neuland Lab Description and Business Overview

Table 122. Neuland Lab Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. Neuland Lab Voriconazole API Product

Table 124. Neuland Lab Recent Development

Table 125. Production Base and Market Concentration Rate of Raw Material

Table 126. Key Suppliers of Raw Materials

Table 127. Voriconazole API Distributors List

Table 128. Voriconazole API Customers List

Table 129. Voriconazole API Market Trends

Table 130. Voriconazole API Market Drivers

Table 131. Voriconazole API Market Challenges

Table 132. Voriconazole API Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Voriconazole API Product Picture

Figure 2. Global Voriconazole API Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Voriconazole API Sales Market Share by Type in 2024 & 2031

Figure 4. Oral Grade Product Picture

Figure 5. Injection Grade Product Picture

Figure 6. Global Voriconazole API Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Voriconazole API Sales Market Share by Application in 2024 & 2031

Figure 8. Voriconazole Tablets Examples

Figure 9. Voriconazole Injection Examples

Figure 10. Global Voriconazole API Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Voriconazole API Sales Growth Rate (2020-2031) & (US$ Million)

Figure 12. Global Voriconazole API Sales (Ton) Growth Rate (2020-2031)

Figure 13. Global Voriconazole API Price Trends Growth Rate (2020-2031) & (US$/Ton)

Figure 14. Voriconazole API Report Years Considered

Figure 15. Global Market Voriconazole API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 16. Global Voriconazole API Revenue Market Share by Region: 2020 VS 2024

Figure 17. North America Voriconazole API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. North America Voriconazole API Sales (Ton) Growth Rate (2020-2031)

Figure 19. Europe Voriconazole API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Europe Voriconazole API Sales (Ton) Growth Rate (2020-2031)

Figure 21. China Voriconazole API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. China Voriconazole API Sales (Ton) Growth Rate (2020-2031)

Figure 23. Japan Voriconazole API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Japan Voriconazole API Sales (Ton) Growth Rate (2020-2031)

Figure 25. Global Voriconazole API Revenue Share by Type (2020-2025)

Figure 26. Global Voriconazole API Sales Share by Type (2026-2031)

Figure 27. Global Voriconazole API Revenue Share by Type (2026-2031)

Figure 28. Global Voriconazole API Revenue Share by Application (2020-2025)

Figure 29. Global Voriconazole API Revenue Growth Rate by Application in 2020 & 2024

Figure 30. Global Voriconazole API Sales Share by Application (2026-2031)

Figure 31. Global Voriconazole API Revenue Share by Application (2026-2031)

Figure 32. Global Voriconazole API Sales Share by Company (2024)

Figure 33. Global Voriconazole API Revenue Share by Company (2024)

Figure 34. Global 5 Largest Voriconazole API Players Market Share by Revenue in Voriconazole API: 2020 & 2024

Figure 35. Voriconazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 36. Manufacturing Cost Structure of Voriconazole API

Figure 37. Manufacturing Process Analysis of Voriconazole API

Figure 38. Voriconazole API Industrial Chain

Figure 39. Channels of Distribution (Direct Vs Distribution)

Figure 40. Distributors Profiles

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Voriconazole API market? zhanKai

The top companies in the global Voriconazole API market are Dr. Reddy's Laboratories、Murli Krishna Pharma、SGMR Pharmaceuticals.

Related Reports

Voriconazole API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Voriconazole API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 136
USD 3950.00
(Single User License)
Global Voriconazole API Market Research Report 2026
The global Voriconazole API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 141
USD 2900.00
(Single User License)
Global Voriconazole API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Voriconazole API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 160
USD 4900.00
(Single User License)
Global Voriconazole API Market Research Report 2025
The global market for Voriconazole API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 104
USD 2900.00
(Single User License)
Voriconazole API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Voriconazole API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 128
USD 3950.00
(Single User License)
Global Voriconazole API Market Insights, Forecast to 2030
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published Date: 2024-04-12
Pages: 111
USD 4900.00
(Single User License)
Global Voriconazole API Market Research Report 2024
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published Date: 2024-01-17
Pages: 95
USD 2900.00
(Single User License)
Voriconazole API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published Date: 2024-01-09
Pages: 130
USD 3950.00
(Single User License)

Voriconazole API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Voriconazole API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 136
USD 3950.00 (Single User License)
Global Voriconazole API Market Research Report 2026
The global Voriconazole API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 141
USD 2900.00 (Single User License)
Global Voriconazole API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Voriconazole API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 160
USD 4900.00 (Single User License)
Global Voriconazole API Market Research Report 2025
The global market for Voriconazole API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 104
USD 2900.00 (Single User License)
Voriconazole API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Voriconazole API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 128
USD 3950.00 (Single User License)
Global Voriconazole API Market Insights, Forecast to 2030
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published: 2024-04-12
Pages: 111
USD 4900.00 (Single User License)
Global Voriconazole API Market Research Report 2024
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published: 2024-01-17
Pages: 95
USD 2900.00 (Single User License)
Voriconazole API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published: 2024-01-09
Pages: 130
USD 3950.00 (Single User License)